Clinical Trials Directory

Trials / Completed

CompletedNCT03769519

AdheRence to Inhaled Corticosteroids in Asthma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
29 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

It is widely recognized that asthma in adult African American patients is a significant health problem, which is partly affected by relatively low inhaled corticosteroid (ICS) adherence rates. The goal of this study is to pilot test an ICS adherence intervention, ARICA, that aims to improve ICS adherence in adult African Americans.

Detailed description

The investigators will evaluate ARICA in Duke primary care clinics to study its feasibility and acceptability using a quasi-experimental pre-post study design. The study will enroll between 32 and 48 adult African Americans with persistent asthma and suboptimal ICS adherence, and their health care providers, to study the use of the intervention and key indicators of the intervention's potential effectiveness.

Conditions

Interventions

TypeNameDescription
BEHAVIORALARICAPersonalized ARICA (AdheRence to Inhaled Corticosteroids in Asthma) intervention package.

Timeline

Start date
2020-02-27
Primary completion
2020-08-19
Completion
2020-08-19
First posted
2018-12-07
Last updated
2021-12-17
Results posted
2021-12-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03769519. Inclusion in this directory is not an endorsement.

AdheRence to Inhaled Corticosteroids in Asthma (NCT03769519) · Clinical Trials Directory